Macrocyclic inhibitors targeting the serine protease plasmin showed potent enzyme inhibition, advancing macrocyclic drug design for controlling excessive blood clot dissolution — relevant to bleeding disorders.
Key findingMacrocyclic inhibitors targeting the serine protease plasmin showed potent enzyme inhibition, advancing macrocyclic drug design for controlling excess
What the researchers found
Macrocyclic inhibitors targeting the serine protease plasmin showed potent enzyme inhibition, advancing macrocyclic drug design for controlling excessive blood clot dissolution — relevant to bleeding disorders.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Macrocyclic inhibitors for the serine protease plasmin.
Journal of enzyme inhibition and medicinal chemistry, 24(3), 779-94
Citation
Xue, Fengtian; Seto, Christopher T. (2009). Macrocyclic inhibitors for the serine protease plasmin.. Journal of enzyme inhibition and medicinal chemistry, 24(3), 779-94. https://doi.org/10.1080/14756360802364401